Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person nebivolol [extracellular region]
| Class:Id | ChemicalDrug:9610987 |
|---|
| _displayName | nebivolol [extracellular region] |
|---|
| _timestamp | 2018-12-12 00:29:44 |
|---|
| compartment | [Compartment:984] extracellular region |
|---|
| created | [InstanceEdit:9610981] Jassal, Bijay, 2018-06-14 |
|---|
| crossReference | [DatabaseIdentifier:9628137] ChEBI:64022 |
|---|
| disease | [Disease:9608426] hypertension
[Disease:9608422] congestive heart failure |
|---|
| literatureReference | [LiteratureReference:9611076] A comparison of the beta1-selectivity of three beta1-selective beta-blockers
[LiteratureReference:9611129] Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients
[LiteratureReference:9611101] Human beta 1- and beta 2-adrenergic receptor binding and mediated accumulation of cAMP in transfected Chinese hamster ovary cells. Profile of nebivolol and known beta-adrenergic blockers
[LiteratureReference:9611107] Nebivolol: third-generation beta-blockade |
|---|
| modified | [InstanceEdit:9613282] Jassal, Bijay, 2018-07-13
[InstanceEdit:9616750] Weiser, JD
[InstanceEdit:9616752] Shorser, Solomon, 2018-08-13
[InstanceEdit:9619953] Wu, G, 2018-09-19
[InstanceEdit:9625065] Jassal, Bijay, 2018-10-18
[InstanceEdit:9627975] Wu, G, 2018-11-05
[InstanceEdit:9631716] Wu, G, 2018-12-12 |
|---|
| name | nebivolol |
|---|
| referenceEntity | [ReferenceTherapeutic:9610986] nebivolol [Guide to Pharmacology:7246] |
|---|
| stableIdentifier | [StableIdentifier:9611013] R-ALL-9610987.2 |
|---|
| (hasMember) | [DefinedSet:9609307] β-blockers [extracellular region] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by nebivolol [extracellular region] (9610987)